UBS Group AG - INMED PHARMACEUTICALS INC ownership

INMED PHARMACEUTICALS INC's ticker is and the CUSIP is 457637601. A total of 10 filers reported holding INMED PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of INMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$48
-98.3%
69
-97.4%
0.00%
Q1 2023$2,832
+68.7%
2,622
+215.5%
0.00%
Q4 2022$1,679
-95.6%
831
-85.7%
0.00%
Q3 2022$38,0005,7970.00%
Other shareholders
INMED PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Virtu Financial LLC 17,724$360.01%
ARMISTICE CAPITAL, LLC 97,163$196,2690.00%
ROYAL BANK OF CANADA 11$00.00%
Advisory Services Network, LLC 6$120.00%
TCI Wealth Advisors, Inc. 5$100.00%
UBS Group AG 831$1,6790.00%
AllSquare Wealth Management LLC 21$420.00%
OSAIC HOLDINGS, INC. 74$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 1$20.00%
View complete list of INMED PHARMACEUTICALS INC shareholders